semaglutide soul (Semaglutide cardiOvascular oUtcomes triaL) in individuals with soul trial oral semaglutide cardiovascular

That date is only a few months away

Patrick Kee, MD, PhD, a cardiologist at Vital Heart & Vein, who was not involved in the study, noted the following about the studys results: The investigators demonstrated that the therapeutic efficacy of semaglutide on the primary cardiovascular composite endpoint indeed emerged early and persisted over the initial three months (hazard ratio [HR] 0.63, 95% confidence interval [CI] 0.41-0.95) and the subsequent six months (HR 0.60, 95% CI 0.44-0.81). While the underlying mechanisms of semaglutides early clinical benefits remain under investigation, these findings suggest an encouraging intervention capable of altering the trajectory of [patients with obesity] with established cardiovascular disease but without a diagnosis of diabetes, he told Medical News Today

Average weight loss is typically 12 pounds per week, with more visible results after the first month

People diagnosed with NAION can talk to an attorney about their legal options and eligibility for joining this active litigation

it did not fall by 4% in 2023.